Disease Control Priorities, third edition (DCP3) compiles the global health knowledge of institutions and experts from around the world, a task that required the efforts of over 500 individuals, including volume editors, chapter authors, peer reviewers, advisory committee members, and research and staff assistants. For each of these contributions we convey our acknowledgement and appreciation. First and fore- most, we would like to thank our 33 volume editors who provided the intellectual vision for their volumes based on years of professional work in their respective fields, and then dedicated long hours to reviewing each chapter, providing leadership and guidance to authors, and framing and writing the summary chapters. We also thank our chapter authors who collectively volunteered their time and expertise to writing over 160 comprehensive, evidence-based chapters.
We owe immense gratitude to the institutional sponsor of this effort: The Bill & Melinda Gates Foundation. The Foundation provided sole financial support of the Disease Control Priorities Network. Many thanks to Program Officers Kathy Cahill, Philip Setel, Carol Medlin, and (currently) Damian Walker for their thoughtful interactions, guidance, and encouragement over the life of the project. We also wish to thank Jaime Sepúlveda for his longstanding support, including chairing the Advisory Committee for the second edition and, more recently, demonstrating his vision for DCP3 while he was a special advisor to the Gates Foundation. We are also grateful to the University of Washington’s Department of Global Health and successive chairs King Holmes and Judy Wasserheit for providing a home base for the DCP3 Secretariat, which included intellectual collaboration, logistical coordination, and administrative support.
We thank the many contractors and consultants who provided support to specific volumes in the form of economic analytical work, volume coordination, chapter drafting, and meeting organization: the Center for Disease Dynamics, Economics, & Policy; Center for Chronic Disease Control; Center for Global Health Research; Emory University; Evidence to Policy Initiative; Public Health Foundation of India; QURE Healthcare; University of California, San Francisco; University of Waterloo; University of Queensland; and the World Health Organization.
We are tremendously grateful for the wisdom and guidance provided by our advisory committee to the editors. Steered by Chair Anne Mills, the advisory committee assures quality and intellectual rigor of the highest order for DCP3.
The National Academies of Science, Engineering, and Medicine, in collaboration with the Interacademy Medical Panel, coordinated the peer-review process for all DCP3 chapters. Patrick Kelley, Gillian Buckley, Megan Ginivan, and Rachel Pittluck managed this effort and provided critical and substantive input.
The World Bank External and Corporate Relations Publishing and Knowledge division provided exceptional guidance and support throughout the demanding production and design process. We would particularly like to thank Carlos Rossel, the publisher; Mary Fisk, Nancy Lammers, Rumit Pancholi, and Deborah Naylor for their diligence and expertise. Additionally, we thank Jose de Buerba, Mario Trubiano, Yulia Ivanova, and Chiamaka Osuagwu of the World Bank for providing professional counsel on communications and marketing strategies.
Several U.S. and international institutions contributed to the organization and execution of meetings that supported the preparation and dissemination of DCP3.
We would like to express our appreciation to the following institutions:
University of Bergen, consultation on equity (June 2011)
University of California, San Francisco, surgery volume consultations (April 2012, October 2013, February 2014)
Institute of Medicine, first meeting of the Advisory Committee to the Editors ACE (March 2013)
Harvard Global Health Institute, consultation on policy measures to reduce incidence of noncommunicable diseases (July 2013)
Institute of Medicine, systems strengthening meeting (September 2013)
Center for Disease Dynamics, Economics, and Policy (Quality and Uptake meeting Sept 2013, reproductive and maternal health volume consultation November 2013)
National Cancer Institute cancer consultation (November 2013)
Union for International Cancer Control cancer consultation (November 2013, December 2014)
Carol Levin provided outstanding governance for cost and cost-effectiveness analysis. Stéphane Verguet added invaluable guidance in applying and improving the extended cost-effectiveness analysis method. Shane Murphy, Zachary Olson, Elizabeth Brouwer, Kristen Danforth, David Watkins, Jennifer Nguyen, and Jennifer Grasso provided exceptional research assistance and analytic assistance. Brianne Adderley ably managed the budget and project processes. The efforts of these individuals were absolutely critical to producing this series, and we are thankful for their commitment.